Successful treatment of haemolytic uraemic syndrome with recombinant tissue-type plasminogen activator.
Kruez
W
W
Linde
R
R
Becker
S
S
Seifried
E
E
D002675:Child, Preschool; D003404:Creatinine / Q000378:metabolism; D005260:Female; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis; D006463:Hemolytic-Uremic Syndrome / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D006801:Humans; D007668:Kidney / Q000503:physiopathology; D011994:Recombinant Proteins / Q000627:therapeutic use; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*
D005338:Fibrin Fibrinogen Degradation Products; D011994:Recombinant Proteins; D003404:Creatinine; D010959:Tissue Plasminogen Activator